Skip to main content
Clinical Trials/NCT01977274
NCT01977274
Active, not recruiting
Not Applicable

Predictive Clinical and Biological Parameters in Gynecological Cancer - GC-BIO-IPC 2013-010

Institut Paoli-Calmettes1 site in 1 country300 target enrollmentDecember 1, 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Ovarian Cancer
Sponsor
Institut Paoli-Calmettes
Enrollment
300
Locations
1
Primary Endpoint
molecular alteration in gynecological cancer
Status
Active, not recruiting
Last Updated
last month

Overview

Brief Summary

Research of predictive clinical and biological factors in breast cancer : genomic, proteomic, mutation

Registry
clinicaltrials.gov
Start Date
December 1, 2013
End Date
December 1, 2035
Last Updated
last month
Study Type
Interventional
Study Design
Single Group
Sex
Female

Investigators

Sponsor
Institut Paoli-Calmettes
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • gynecological cancer suspicion
  • age \> 18
  • signed informed consent

Exclusion Criteria

  • \- emergency
  • Exclusion criteria after histological exam Any diagnosis that is not a gynecological cancer (ovarian, cervix, endometrium).

Outcomes

Primary Outcomes

molecular alteration in gynecological cancer

Time Frame: average of 4 weeks after diagnosis

gene expression level

Secondary Outcomes

  • relation between molecular alteration and clinical and histological characteristics(up to 10 years)

Study Sites (1)

Loading locations...

Similar Trials